EUFEMED is the European not-for-profit association for the exchange of information, guidance and opinion between sponsors, national agencies, research units and study participants on the practice of early clinical development of medicines with the ultimate goal of improving therapeutic options for individual patients and society as a whole.
EUFEMED offers opportunities to share and debate information on new models in medicines development and best practice of applied human pharmacology in conferences, workshops and webinars, and through the development of reference materials and publications.
Education and Training
EUFEMED develops and delivers education and training to improve and support the conduct and practice of early clinical development of medicines.
EUFEMED promotes the best interests of study participants and fosters the safe practice of human pharmacology in clinical trial planning, conduct and reporting among all stakeholders involved in early medicines development.
EUFEMED facilitates networking between stakeholders of human pharmacology through its member associations by organising discussion and meeting opportunities at a European level.
As a collective, EUFEMED represents its members in public consultations and discussions on future legislation and operational practices in early medicines development with regulatory agencies, governments, non-government organisations, industry and academia, with the aim of ensuring that appropriate recognition is given to the importance of developing new medicines in Europe.